Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses

Molecular Cell
J YuEileen D Adamson

Abstract

Related coactivators p300 and CBP affect the transcriptional activities of many transcription factors (TF), producing multiple downstream effects. Here we show that immediate early response TF, Egr1, acts upstream of p300/CBP to induce or to repress transcription, depending on the stimulus. Cells induced with serum to increase endogenous Egr1 increase the transcription of p300/CBP only when Egr1 binding sites in the promoter are not mutated, causing the expression of downstream targets of Egr1 which leads to survival and growth. Induction of p300/CBP by Egr1 results in acetylation and stabilization of Egr1 and transactivation of survival genes but repression of Egr1 and p300/CBP in negative feedback loops. In contrast, induction of Egr1 by UV-C irradiation leads to repression of p300/CBP transcription: Egr1 is preferentially phosphorylated, leading to regulation of target genes that cause cell death. This complex balance of opposing effects appears to finely modulate important cellular life and death responses.

References

Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·P LemaireP Charnay
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·B A ChristyD Nathans
Nov 1, 1994·The Journal of Cell Biology·S M Frisch
May 16, 1994·Biochemical and Biophysical Research Communications·R P Huang, E D Adamson
Apr 1, 1996·The Journal of Cell Biology·R P HuangE D Adamson
Nov 15, 1996·The Journal of Biological Chemistry·M M AhmedV M Rangnekar
Jun 19, 1997·Nature·N L LillD M Livingston
Jul 3, 1997·International Journal of Cancer. Journal International Du Cancer·R P HuangE D Adamson
Aug 8, 1997·The Journal of Biological Chemistry·P NairV M Rangnekar
Jan 31, 1998·The Journal of Biological Chemistry·M M AhmedV M Rangnekar
Aug 26, 1998·International Journal of Cancer. Journal International Du Cancer·R P HuangA L Boynton
Oct 13, 1999·Molecular Cell·N ShikamaN B La Thangue
Jul 25, 2000·BioTechniques·I de BelleE D Adamson
Jan 3, 2001·Nature Medicine·S A AbdulkadirJ Milbrandt
Jun 4, 2002·Nature Reviews. Molecular Cell Biology·Steven M Frisch, Joe S Mymryk
Jan 31, 2003·The Journal of Biological Chemistry·Thierry VirolleDan Mercola
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Anja Krones-HerzigDan Mercola
Jan 31, 2004·Annals of the New York Academy of Sciences·Véronique BaronDan Mercola

❮ Previous
Next ❯

Citations

Sep 23, 2006·Cell Death and Differentiation·J YuE D Adamson
Jan 11, 2007·Immunology and Cell Biology·Amanda M de MestreMark D Hulett
Oct 6, 2007·Current Opinion in Rheumatology·Maria Trojanowska, John Varga
Jul 19, 2005·Molecular and Cellular Biology·Remy PedeuxCurtis C Harris
Mar 30, 2012·BMC Genomics·Yuanpeng ZhouWeidong Tian
Oct 2, 2009·Future Oncology·Delphine Gitenay, Véronique T Baron
May 31, 2011·Frontiers in Bioscience (Landmark Edition)·Michael F RitchieJonathan Soboloff
Feb 14, 2014·Cellular and Molecular Life Sciences : CMLS·Dirk-Jan Saaltink, Erno Vreugdenhil
Apr 23, 2011·Matrix Biology : Journal of the International Society for Matrix Biology·Swati BhattacharyyaJohn Varga
Feb 17, 2009·Seminars in Fetal & Neonatal Medicine·Ian C G Weaver
Jun 27, 2014·BioMed Research International·Daniela BastianelliElena De Falco
Nov 18, 2014·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Zhijun ChenShunichi Murakami
Dec 31, 2005·Annals of the New York Academy of Sciences·Sarki A Abdulkadir
Sep 1, 2007·Journal of Periodontal Research·L PhamS Tetradis
Nov 22, 2007·International Journal of Cancer. Journal International Du Cancer·Mandy WagnerIngo Tamm
Mar 16, 2016·BMC Musculoskeletal Disorders·Guus G H van den AkkerJan Willem Voncken
Dec 5, 2009·Birth Defects Research. Part C, Embryo Today : Reviews·Ian C G Weaver
Aug 13, 2008·Brain Research·Patrick O McGowanMoshe Szyf
Jan 14, 2012·The Biochemical Journal·Ning LiuXiaoying Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis